These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32801036)

  • 1. Assigning likelihood ratios to immunoblot assay results: A clinical approach in autoimmune reporting.
    Infantino M; Manfredi M; Carbone T; Bistoni O; Cipriani S; Gerli R; Bizzaro N
    Autoimmun Rev; 2020 Oct; 19(10):102635. PubMed ID: 32801036
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoblot assay in differential diagnosis of autoimmune blistering skin diseases.
    Pas HH
    Clin Dermatol; 2001; 19(5):622-30. PubMed ID: 11604310
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic approach to autoimmune blistering diseases using immunoblotting with chemiluminescence.
    Kitamura T; Tamada Y; Takama H; Yokochi K; Nitta Y; Ikeya T
    J Dermatol; 1994 Sep; 21(9):652-4. PubMed ID: 7962968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the effectiveness of autoantibody testing in the clinic.
    Sturgess A; Edmonds J
    Autoimmun Rev; 2002 Oct; 1(5):273-8. PubMed ID: 12848980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of immunofluorescence in the diagnosis of autoimmune bullous dermatoses.
    Jukić IL; Marinović B
    Clin Dermatol; 2011; 29(4):389-97. PubMed ID: 21679866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice.
    Deane KD; Van Hoovels L; Joy VE; Olschowka N; Bossuyt X
    Autoimmun Rev; 2024 May; 23(5):103537. PubMed ID: 38565401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical contribution of myositis-related antibodies detected by immunoblot to idiopathic inflammatory myositis: A one-year retrospective study.
    Lecouffe-Desprets M; Hémont C; Néel A; Toquet C; Masseau A; Hamidou M; Josien R; Martin JC
    Autoimmunity; 2018 Mar; 51(2):89-95. PubMed ID: 29463118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting.
    Oyama N; Bhogal BS; Carrington P; Gratian MJ; Black MM
    Br J Dermatol; 2003 May; 148(5):939-44. PubMed ID: 12786824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of autoantibodies].
    Conrad K; Steinmann J; Kabelitz D; Rieber EP
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1005-10. PubMed ID: 11555775
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential use of immunoblots for characterization of autoantibody specificities.
    Bartsch H; Bachmann M
    Methods Mol Biol; 2009; 536():293-8. PubMed ID: 19378068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of an automated enzyme inhibition assay for the detection of anti-mitochondrial M2 autoantibodies.
    Schmit P; Gilson G; Humbel RL
    Clin Chem; 1999 Dec; 45(12):2287-9. PubMed ID: 10585372
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoantibodies in clinical practice].
    Terrier B; Mouthon L
    Rev Mal Respir; 2006 Dec; 23(6):743-5. PubMed ID: 17886349
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of autoantibodies against thyroid peroxidase in autoimmune thyroid disease: evidence against antibodies directly inhibiting peroxidase activity as regulatory factors in thyroid hormone metabolism.
    Saller B; Hörmann R; Mann K
    J Clin Endocrinol Metab; 1991 Jan; 72(1):188-95. PubMed ID: 1702446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Marker antibodies of autoimmune diseases and their clinical significance].
    Akizuki M
    Nihon Rinsho; 1988 Apr; 46(4):829-36. PubMed ID: 2900344
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of different methods for the detection of autoantibodies in autoimmune diseases.
    Grigolo B; Mazzetti I; Borzi RM; Meliconi R; Origgi L; Scorza R; Facchini A
    Int J Clin Lab Res; 1995; 25(4):205-10. PubMed ID: 8788549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extract of cultured A431 cells contains major tissue antigens of autoimmune bullous diseases.
    Lee CW
    Br J Dermatol; 2000 Oct; 143(4):821-3. PubMed ID: 11069463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-organ specific anticytoplasmic autoantibodies. Immunoserologic detection and diagnostic relevance].
    Blaschek MA
    Wien Med Wochenschr; 1987 Jul; 137(13):303-9. PubMed ID: 3307168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The measurement of antithyroid autoantibodies in the diagnosis and management of thyroid autoimmune disease.
    Kraiem Z
    Clin Rev Allergy Immunol; 1998; 16(3):219-25. PubMed ID: 9773249
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of determination of autoantibodies in autoimmune diseases].
    Glisić B; Stefanović D; Popović M; Mitrović D
    Vojnosanit Pregl; 1999; 56(4):407-17. PubMed ID: 10528528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.